NDAORALTABLET
Approved
Apr 1956
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
1
Data completeness
4/8 — Partial
ATARAX (hydroxyzine hydrochloride) by Pfizer is clinical pharmacology atarax is unrelated chemically to the phenothiazines, reserpine, meprobamate, or the benzodiazepines. Approved for anxiety. First approved in 1956.
Drug data last refreshed 20h ago
Mechanism of Action
CLINICAL PHARMACOLOGY Atarax is unrelated chemically to the phenothiazines, reserpine, meprobamate, or the benzodiazepines. Atarax is not a cortical depressant, but its action may be due to a suppression of activity in certain key regions of the subcortical area of the central nervous system.…
Indications (1)
Clinical Trials (1)
Prospective Validation of Ataraxis AI Test for Predicting Treatment Response in Neoadjuvant Breast Cancer
Started Jan 2026
150 enrolled
Breast Cancer
Worked on ATARAX at Pfizer? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.